Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R413 (MIMI_R413)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder

Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.

Lead Time
Delivery times vary depending on the purchase method and location. Contact your local distributor for precise delivery estimates.

Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.

The tag type is determined during production. To request a specific tag type, please inform us in advance; we will prioritize its development.

Synonyms
MIMI_R413; Uncharacterized protein R413
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-355
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Acanthamoeba polyphaga mimivirus (APMV)
Target Names
MIMI_R413
Target Protein Sequence
MSYFYEKCNC KTSITYSFFM DKLEKLEKMS TIINNFDLES YGLKYYCQYP DCKKCQTNQF YQLENIIWPN NIRHIIKHHH SYPSKYFTNI VIYTVCTNDY IINPPIKINT KNISDFSYVQ LSYNKLLIID ALFRQGSYPR YLVPKNHSNP STRFIYSEHS GVLTLKNSVI DNIIVSTESS RIDSNDTDIY LPTNIDLMKN HEFLFHTHPN SITYAGRLKN NIIYEFPSAN DILNFIKYHN TGIAQASIIA APEGIYVIRP IEYNRDFKIN LENFTDLKKY ILKLENKAVK KLSDVPNLSD PDTFHENVSH NFSYIKLYNK YIRQYNIFVE FYPRKKKNNE WILPSIYLQR ISTSK
Uniprot No.

Q&A

What is the genomic context of the R413 protein within the mimivirus genome?

The R413 protein is one of approximately 1000 proteins encoded by the mimivirus genome, which spans about 1.2 Mb . Like many mimivirus proteins, R413 remains uncharacterized, meaning its function has not been experimentally determined. In the mimivirus genome, genes are assigned identifiers based on their position and orientation, with R-numbered genes typically located on one strand of the genome. Understanding the genomic context is important because genes located near each other sometimes have related functions or are co-expressed during specific phases of viral replication .

How does R413 compare to other uncharacterized mimivirus proteins?

R413 belongs to a substantial group of mimivirus proteins categorized as ORFans - open reading frames with little or no homology to known sequences in current databases . The mimivirus genome contains four main groups of ORFs: Megavirales core genes, genes involved in lateral gene transfer, duplicated genes, and ORFans . To properly contextualize R413, researchers should compare its sequence characteristics, expression patterns during infection, and any structural predictions with other uncharacterized proteins to identify potential functional relationships or unique features.

What preliminary evidence exists regarding the expression timing of R413 during infection?

While the search results don't specifically mention R413's expression timing, mimivirus gene expression generally follows a temporal pattern similar to other DNA viruses, with early, intermediate, and late phases . Understanding when R413 is expressed during the infection cycle would provide valuable clues about its potential function. Early proteins often participate in host interaction or viral genome replication, while late proteins frequently have structural roles in virion assembly . Researchers should conduct RT-PCR or RNA-seq analysis at different time points post-infection to determine R413's expression profile.

What expression systems are most suitable for producing recombinant MIMI_R413 protein?

For expressing recombinant mimivirus proteins, several systems can be considered based on the protein's characteristics:

Expression SystemAdvantagesDisadvantagesBest For
E. coliHigh yield, simple cultivation, economicalLimited post-translational modifications, potential folding issuesSoluble, non-toxic proteins without complex modifications
Yeast (S. cerevisiae, P. pastoris)Eukaryotic folding machinery, some post-translational modificationsLower yield than bacteria, longer cultivation timeProteins requiring disulfide bonds or glycosylation
Insect cellsAdvanced eukaryotic modifications, good for complex proteinsMore expensive, technically demandingProteins needing extensive post-translational modifications
Mammalian cellsMost sophisticated modification capacityHighest cost, lowest yield, most complexProteins where authentic folding and modification are critical

For R413 specifically, an initial attempt with E. coli using a fusion tag (His, GST, or MBP) would be reasonable, followed by more complex systems if solubility or activity issues arise. The addition of solubility-enhancing tags and optimization of expression conditions (temperature, media composition, induction timing) significantly impact success rates with uncharacterized proteins .

What are the most informative approaches for functional characterization of R413?

A multi-faceted approach is essential for characterizing the function of an uncharacterized protein like R413:

  • Bioinformatic analysis:

    • Sequence analysis for conserved domains and motifs

    • Structural prediction using tools like AlphaFold

    • Comparative analysis across viral families

  • Localization studies:

    • Fluorescent tagging to determine subcellular localization during infection

    • Co-localization with known viral structures (e.g., viral factories)

  • Interaction studies:

    • Immunoprecipitation followed by mass spectrometry

    • Yeast two-hybrid or proximity labeling approaches

    • Co-immunoprecipitation with suspected partners

  • Loss-of-function studies:

    • Gene silencing approaches similar to those used for R458

    • Assessment of effects on viral replication, protein expression, and fitness

    • Complementation studies with the wild-type protein

  • Biochemical characterization:

    • In vitro activity assays based on structural predictions

    • Assessment of DNA/RNA binding capacity

    • Testing for enzymatic activities (kinase, protease, etc.)

Each approach contributes complementary information, eventually converging on a functional model.

How can gene silencing be optimized for studying R413 function during infection?

Based on successful silencing experiments with other mimivirus genes like R458, the following approaches can be optimized for R413 :

  • siRNA design:

    • Multiple siRNAs targeting different regions of the R413 mRNA

    • Control siRNAs with scrambled sequences

    • Careful design to avoid off-target effects

  • Delivery optimization:

    • Transfection of host Acanthamoeba before viral infection

    • Optimization of transfection reagent and conditions

    • Testing different time points between transfection and infection

  • Silencing verification:

    • RT-qPCR to quantify R413 mRNA levels

    • Western blotting to confirm protein reduction

    • Standardization against housekeeping genes/proteins

  • Phenotypic analysis:

    • DNA replication (qPCR)

    • Virus production (titration assays)

    • Protein expression profiles (proteomics)

    • Viral fitness in competition assays

As demonstrated with the R458 initiation factor, silencing may not completely block viral replication but can reveal effects on protein expression and viral fitness that provide insights into function .

How might R413 interact with host cell pathways during mimivirus infection?

Understanding potential interactions between R413 and host cell pathways requires consideration of the major host changes during mimivirus infection:

  • Translation and protein synthesis:
    Mimivirus encodes multiple translation-related factors , suggesting the importance of controlling protein synthesis. While R413 is not among the known translation factors (R458, L496, R464, R624, R726), it could potentially be involved in regulating these factors or interacting with host translation machinery.

  • Cell cycle regulation:
    Mimivirus infection causes cell cycle arrest, with downregulation of genes involved in DNA replication, repair, and mitotic processes . R413 could potentially contribute to this modulation by interacting with host cell cycle regulators.

  • Cytoskeletal reorganization:
    Infection leads to the dismantling of the host cytoskeleton , which may be necessary for viral factory formation. R413 might participate in this process through direct or indirect interactions with cytoskeletal components.

  • Membrane remodeling:
    The translocation of endoplasmic reticulum membranes to viral factory areas is a key feature of mimivirus infection . R413 could be involved in recruiting or modifying host membranes for viral replication.

Experimental approaches to investigate these possibilities include co-immunoprecipitation with host proteins, localization studies during different stages of infection, and comparative proteomics between wild-type and R413-silenced infections.

What structural characteristics might inform R413 function prediction?

While specific structural information about R413 is not provided in the search results, several approaches can be used to predict structural characteristics:

  • Primary sequence analysis:

    • Identification of conserved motifs and domains

    • Prediction of post-translational modification sites

    • Assessment of hydrophobicity patterns and transmembrane regions

  • Secondary structure prediction:

    • Analysis of alpha-helical and beta-sheet content

    • Identification of potential disordered regions

    • Recognition of structural motifs associated with specific functions

  • Tertiary structure modeling:

    • Ab initio structure prediction using tools like AlphaFold2

    • Structural comparison with proteins of known function

    • Identification of potential active sites or binding pockets

  • Quaternary structure considerations:

    • Prediction of oligomerization potential

    • Analysis of potential interfaces for protein-protein interactions

Structural features that might be particularly informative include the presence of nucleotide-binding motifs (suggesting involvement in replication or transcription), membrane-association domains (indicating roles in viral factory formation), or structural similarity to translation factors (suggesting roles in protein synthesis).

How does the host transcriptome response to mimivirus infection provide context for understanding R413 function?

The host transcriptome undergoes significant changes during mimivirus infection that may provide context for understanding R413 function:

Time Post-InfectionMajor Host Transcriptome ChangesPotential Implications for R413 Function
1 hourUpregulation of translation regulation and mitochondrial genes; general stress response If R413 is expressed early, it may interact with these pathways to establish infection
3 hoursDownregulation of DNA replication, DNA repair, and nucleotide metabolism genes; cell cycle arrest If expressed at this stage, R413 might contribute to redirecting cellular resources toward viral replication
5 hoursChanges affecting cytoskeleton and translocation of ER membranes to viral factories Late expression would suggest involvement in viral factory maturation or virion assembly

By correlating R413 expression timing with these host changes and identifying potential interactions with affected host pathways, researchers can generate testable hypotheses about its function. Comparative transcriptomics between wild-type infections and infections with R413 silenced would further illuminate its role in modulating host responses.

What are the best approaches for developing specific antibodies against R413?

Developing specific antibodies against uncharacterized proteins like R413 requires careful planning:

  • Antigen design options:

    • Full-length recombinant protein: Provides comprehensive epitope coverage but may face expression/solubility challenges

    • Synthetic peptides: Easier to produce but limited to linear epitopes

    • Domain-specific fragments: Balance between specificity and producibility

  • Production strategies:

    • Polyclonal antibodies: Faster development, multiple epitopes recognized, higher sensitivity

    • Monoclonal antibodies: Greater specificity, consistent production, better for quantitative applications

    • Recombinant antibodies: Highly reproducible, amenable to engineering

  • Validation approaches:

    • Western blotting against recombinant protein and viral lysates

    • Immunoprecipitation followed by mass spectrometry

    • Immunofluorescence with appropriate controls

    • Testing in R413-silenced infections

  • Alternative approaches:

    • Epitope tagging of R413 in recombinant mimivirus

    • Proximity labeling approaches (BioID, APEX)

    • Nanobody development

The development of specific antibodies is crucial for many downstream applications, including localization studies, interaction analyses, and functional characterization of R413.

How can comparative proteomics be optimized to study R413 function?

Comparative proteomics offers powerful insights into R413 function by examining how its presence or absence affects the viral and host proteome:

  • Experimental design considerations:

    • Comparison between wild-type and R413-silenced infections

    • Time-course sampling to capture dynamic changes

    • Fractionation to enrich for specific subcellular compartments

    • SILAC or TMT labeling for accurate quantification

  • Sample preparation optimization:

    • Efficient viral and host protein extraction

    • Appropriate protease digestion (trypsin, LysC, etc.)

    • Removal of interfering compounds

    • Peptide fractionation to increase proteome coverage

  • Mass spectrometry approaches:

    • Data-dependent acquisition for discovery proteomics

    • Data-independent acquisition for comprehensive analysis

    • Targeted proteomics for specific pathway monitoring

    • Crosslinking mass spectrometry for structural interactions

  • Bioinformatic analysis strategies:

    • Pathway enrichment analysis

    • Protein-protein interaction network construction

    • Temporal clustering of expression patterns

    • Integration with transcriptomic data

The search results mention comparative proteomics being used to study wild-type mimivirus , and similar approaches would be valuable for understanding R413's functional context.

What considerations are important when designing experiments to determine if R413 affects viral fitness?

Assessing the impact of R413 on viral fitness requires carefully designed experiments:

  • Competition assays:

    • Co-infection with wild-type virus and R413-silenced/mutant virus

    • Monitoring relative abundance over multiple passages

    • Quantification using sequence-specific qPCR or next-generation sequencing

  • Growth kinetics assessment:

    • Single-step and multi-step growth curves

    • Measurement of viral DNA replication

    • Quantification of infectious particle production

    • Assessment of plaque size and morphology

  • Host range testing:

    • Infection of different Acanthamoeba species

    • Testing in alternative potential hosts

    • Comparative fitness across different host backgrounds

  • Stress condition evaluation:

    • Thermal stability

    • pH tolerance

    • Resistance to desiccation

    • Survival in environmental samples

  • Genetic complementation:

    • Rescue experiments with wild-type R413

    • Structure-function analysis using mutant variants

Similar approaches were used to demonstrate that silencing of R458 (translation initiation factor) affects mimivirus fitness, even though it does not completely prevent viral multiplication . These methodologies would likely reveal whether R413 contributes to viral fitness and under what conditions it becomes particularly important.

How does R413 relate to the broader mimivirus translation machinery?

Mimivirus encodes an unusually complete set of translation-related components for a virus, including:

Component TypeExamples in MimivirusPossible Relationship to R413
Aminoacyl-tRNA synthetasesArginyl-RS (R663), Cysteinyl-RS (L164), Methionyl-RS (R639), Tyrosyl-RS (L124) R413 might function as an unrecognized translation-related factor or regulator of these enzymes
tRNAsLeucine (L46, R875, R902), Histidine (MIMI_gt0002), Cysteine (L276), Tryptophan (R868) R413 could be involved in tRNA modification or trafficking
Translation factorsIF4A (R458), IF4E (L496), SUI1 (R464), eF-TU (R624), eRF1 (R726) R413 might interact with these factors, enhancing their function

While R413 is not among the known translation-related factors, its potential involvement should be investigated through:

  • Co-immunoprecipitation with known translation components

  • Localization studies to determine if it co-localizes with translation machinery

  • Assessment of translation efficiency in R413-silenced infections

  • Structural comparisons with translation-related proteins from other organisms

The search results indicate that translation factors like R458 contribute to viral fitness , suggesting that any role R413 might play in translation could be similarly important.

What evolutionary insights might R413 characterization provide regarding mimivirus origins?

Characterizing R413 could contribute to understanding mimivirus evolution in several ways:

  • Phylogenetic analysis:

    • Comparison with proteins from other giant viruses

    • Identification of distant homologs in cellular organisms

    • Assessment of evolutionary rate compared to core viral genes

  • Domain architecture analysis:

    • Identification of domain shuffling events

    • Recognition of novel domain combinations

    • Detection of host-derived domains

  • Lateral gene transfer investigation:

    • Examination of codon usage patterns

    • Analysis of GC content compared to surrounding genomic regions

    • Assessment of gene synteny across related viruses

  • Functional innovation exploration:

    • Identification of novel functional adaptations

    • Understanding of mimivirus-specific features

    • Recognition of repurposed cellular functions

The mimivirus genome contains genes acquired by lateral gene transfer from bacteria, archaea, eukaryotes, or other viruses . Determining whether R413 represents such an acquisition or is a mimivirus innovation would contribute to the broader understanding of giant virus evolution.

How might characterization of R413 contribute to understanding mimivirus host range?

Mimivirus was initially isolated from Acanthamoeba polyphaga, but evidence suggests it may have a broader host range, including other Acanthamoeba species and potentially vertebrates . Characterizing R413 could provide insights into host range determinants:

  • Host interaction potential:

    • Identification of R413 binding to host proteins

    • Assessment of conservation across potential host species

    • Investigation of host-specific adaptations

  • Cell entry involvement:

    • Localization during early infection stages

    • Potential role in phagocytosis or viral internalization

    • Interaction with host membrane components

  • Host defense modulation:

    • Potential interference with amoeba defense mechanisms

    • Investigation of interactions with host stress response pathways

    • Assessment of roles in countering host restriction factors

  • Comparative analysis across hosts:

    • Functional conservation when infecting different Acanthamoeba species

    • Expression patterns in different host backgrounds

    • Requirement for successful infection in various hosts

Understanding R413's potential role in host interaction would contribute to the broader question of mimivirus host range expansion and adaptation.

What high-throughput approaches could accelerate R413 functional characterization?

Several high-throughput approaches could expedite the functional characterization of R413:

  • Multi-omics integration:

    • Correlation of transcriptomics, proteomics, and metabolomics data

    • Temporal analysis across infection stages

    • Network-based analysis of potential functional associations

  • Advanced imaging technologies:

    • High-content screening with different cellular markers

    • Live-cell imaging throughout infection

    • Super-resolution microscopy for detailed localization

  • Systematic interaction mapping:

    • Yeast two-hybrid screening against host and viral libraries

    • Protein microarray analysis

    • BioID or APEX proximity labeling with R413 as bait

  • CRISPR-based approaches:

    • Development of CRISPR systems for giant virus genome editing

    • Screening of host factors that modify R413 requirement

    • Creation of viral variants with modified R413

These approaches generate large datasets that require sophisticated computational analysis but can rapidly narrow down potential functions and guide more focused experimental investigations.

How can structural biology contribute to understanding R413 function?

Structural biology offers powerful approaches for elucidating R413 function:

  • Structure determination methods:

    • X-ray crystallography of purified protein

    • Cryo-electron microscopy for protein complexes

    • NMR for dynamic regions and interactions

    • Integrative modeling combining multiple data sources

  • Structure-guided experimental design:

    • Identification of potential active sites for mutagenesis

    • Design of interaction-disrupting mutations

    • Development of structure-based inhibitors as research tools

  • Structure-based computational analyses:

    • Molecular dynamics simulations to study conformational changes

    • Virtual screening for potential binding partners

    • Structural comparison with proteins of known function

  • In situ structural biology:

    • Cryo-electron tomography of infected cells

    • Cellular cryo-electron microscopy

    • Correlative light and electron microscopy

Recent advances in structural prediction with tools like AlphaFold2 make structural insights more accessible even before experimental structures are determined, providing valuable hypotheses to guide functional characterization.

What are the implications of R413 characterization for understanding other giant viruses?

The characterization of R413 has broader implications for understanding giant viruses generally:

  • Comparative virology perspectives:

    • Identification of functional analogs in other giant virus families

    • Understanding of conserved mechanisms across different giant viruses

    • Recognition of mimivirus-specific adaptations

  • Evolutionary biology insights:

    • Contribution to the debate on giant virus origins

    • Understanding of gene acquisition and innovation mechanisms

    • Insights into the evolution of viral complexity

  • Host-virus interaction advances:

    • Elucidation of common strategies for manipulating amoeba hosts

    • Identification of potential broad host range determinants

    • Understanding of viral adaptation to intracellular lifestyles

  • Methodological developments:

    • Establishment of approaches applicable to other uncharacterized giant virus proteins

    • Development of tools for functional genomics in giant viruses

    • Creation of frameworks for systematic characterization

The lessons learned from characterizing R413 will contribute to establishing research paradigms applicable to the many uncharacterized proteins in giant viruses, ultimately advancing our understanding of these complex biological entities.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.